Phase 3 Metastatic Prostate Cancer Clinical Trials
9 recruitingPhase 3
What is a Phase 3 trial?
Phase 3 trials compare the new treatment against the current standard of care in large groups, often hundreds to thousands of participants. Successful Phase 3 results are typically required for regulatory approval.
Showing 1–9 of 9 trials
Recruiting
Phase 3
An Open-label Study Comparing Lutetium (177Lu) Vipivotide Tetraxetan Versus Observation in PSMA Positive OMPC.
Oligometastatic Prostate Cancer (OMPC)
Novartis Pharmaceuticals450 enrolled142 locationsNCT05939414
Recruiting
Phase 3
Platinum and Taxane Chemo in Met Castration Resistant Prostate Cancer Patients With Alterations in DNA Damage Response Genes
Metastatic Prostate CancerMetastatic Castration-resistant Prostate Cancer
Canadian Cancer Trials Group236 enrolled14 locationsNCT06439225
Recruiting
Phase 2Phase 3
Veterans Affairs Seamless Phase II/III Randomized Trial of STAndard Systemic theRapy With or Without PET-directed Local Therapy for Oligometastatic pRosTate Cancer
Prostate CancerMetastatic Prostate CancerOligometastasis+3 more
VA Office of Research and Development464 enrolled20 locationsNCT04787744
Recruiting
Phase 3
Measuring Oncological Value of Exercise and Statin
Breast CancerMetastatic Breast CancerOvarian Cancer+9 more
Tampere University Hospital240 enrolled1 locationNCT05796973
Recruiting
Phase 2Phase 3
Maximal Tumor Eradication for Oligometastatic Prostate Cancer
Oligometastatic Prostate Cancer
RenJi Hospital120 enrolled1 locationNCT06972511
Recruiting
Phase 3
Creatine Supplementation and Resistance Training to Preserve Muscle Mass and Attenuate Cancer Progression
Metastatic Prostate Cancer
University of Utah200 enrolled1 locationNCT06112990
Recruiting
Phase 3
Cytoreductive Prostatectomy Combined With Triple or Dual Systemic Therapy in mHSPC Patients
Metastatic Prostate CancerTherapy, Directly Observed
The First Affiliated Hospital with Nanjing Medical University200 enrolled1 locationNCT06350825
Recruiting
Phase 3
Intermittent Darolutamide Treatment in the Triple Therapy of mHSPC
Metastatic Prostate CancerIntermitent Anti-androgen Therapy
The First Affiliated Hospital with Nanjing Medical University200 enrolled1 locationNCT06177015
Recruiting
Phase 3
Comparing the Efficacy and Safety of Rezvilutamide+ADT+Docetaxel Versus Rezvilutamide +ADT in the mHSPC
Chemotherapy EffectMetastatic Prostate CancerHormone Sensitive Prostate Cancer
The First Affiliated Hospital with Nanjing Medical University200 enrolled1 locationNCT05983783